Mission BioCapital

VC · Cambridge (United States)

VC

Pre-Seed

Seed

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

Mission BioCapital is a venture capital firm dedicated to making pivotal early-stage investments in life sciences companies. Founded in 2009, the firm has established offices in Cambridge, Massachusetts, and San Francisco, California, two of the nation's leading life science clusters. Mission BioCapital supports its portfolio companies through a unique combination of shared lab space, capital investment, and access to strategic partners, assisting entrepreneurial scientists in building successful companies from idea to exit. The firm's investment focus includes therapeutics, diagnostics, medical devices, laboratory tools, and drug delivery. In addition to traditional investments, Mission BioCapital emphasizes company creation by collaborating with academic researchers and entrepreneurs to launch startups based on novel technologies. This approach has led to the establishment of several companies, including ARase Therapeutics, Arclight Therapeutics LLC, Jupiter Bioventures, and Telo Therapeutics. The firm's commitment to fostering innovation is further demonstrated through initiatives like the Platinum Program, which provides resources such as seed capital, lab space, and mentorship to accelerate the development of transformative life sciences startups.

Investment Criteria

Other investors that have backed the same portfolio companies as Mission BioCapital. Expand any entry to see the shared portfolio companies.

• Mission Bay Capital

  28 shared

  Shared portfolio companies

  • Alessa Therapeutics, Inc.
  • Ambagon Therapeutics, Inc.
  • Asher Biotherapeutics, Inc.
  • Avexegen Therapeutics Inc.
  • Avvio Medical, Inc.
  • Bolt Projects Holdings, Inc.
  • Caribou Biosciences, Inc.
  • Circle Pharma, Inc.
  • Dren Bio, Inc.
  • Epiodyne, Inc.
  • Glycomine, Inc.
  • GraphWear Technologies Inc.
  • Invenio Imaging, Inc.
  • LogicInk Corporation
  • MagNap Clinical Trial
  • Mammoth Biosciences, Inc.
  • Nitrase Therapeutics, Inc.
  • Nobell Foods, Inc.
  • Photoswitch Biosciences, Inc.
  • QurAlis Corporation
  • Sound Agriculture Company
  • Symbiome, Inc.
  • SYMIC Biomedical, Inc.
  • Tangible Science, Inc.
  • Telo Therapeutics, Inc.
  • ViewPoint Therapeutics, Inc.
  • Vivace Therapeutics, Inc.
  • Wild Type, Inc.
• 8VC

  3 shared

  Shared portfolio companies

  • Bolt Projects Holdings, Inc.
  • Dren Bio, Inc.
  • Mammoth Biosciences, Inc.
• Novo Holdings

  3 shared

  Shared portfolio companies

  • Glycomine, Inc.
  • Nuvig Therapeutics, Inc.
  • ViewPoint Therapeutics, Inc.
• Pfizer Ventures

  3 shared

  Shared portfolio companies

  • Circle Pharma, Inc.
  • ImmunOs Therapeutics AG
  • Mediar Therapeutics, Inc.
• RA Capital Management

  3 shared

  Shared portfolio companies

  • Ambagon Therapeutics, Inc.
  • Asher Biotherapeutics, Inc.
  • Vivace Therapeutics, Inc.
• Viva BioInnovator

  3 shared

  Shared portfolio companies

  • Mediar Therapeutics, Inc.
  • QurAlis Corporation
  • Telo Therapeutics, Inc.
• Canaan Partners

  2 shared

  Shared portfolio companies

  • Nocion Therapeutics, Inc.
  • Vivace Therapeutics, Inc.
• Chiesi Ventures

  2 shared

  Shared portfolio companies

  • Glycomine, Inc.
  • Sentien Biotechnologies, Inc.
• Decheng Capital

  2 shared

  Shared portfolio companies

  • Mammoth Biosciences, Inc.
  • Shape Therapeutics Inc.
• Droia Oncology Ventures

  2 shared

  Shared portfolio companies

  • Ambagon Therapeutics, Inc.
  • QurAlis Corporation